Phil. nat. Sonja Kleinlogel, Institute of Physiology, Translational Optogenetics Group, University of Bern.
Phil. nat. Sonja Kleinlogel, Institute of Physiology, Translational Optogenetics Group, University of Bern. Courtesy of Sonja Kleinlogel - An interdisciplinary research project of the University of Bern, the Paul Scherrer Institute (PSI), the Humboldt Universität of Berlin (D) and the University of Manchester (UK) will be funded with 10 million euros by the European Research Council (ERC). Over the next six years, the SOL project intends to make cell activities in the entire body controllable by means of light pulses, thus opening new avenues of research opportunities and novel forms of therapy. It is a long-standing dream of modern biology to attain the ability to control cellular activity remotely and non-invasively - and light is a perfect medium for this. The SOL (Switchable rhodOpsins in Life Sciences) research project is designed to make this dream come true.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
Your Benefits
- Access to all content
- Receive newsmails for news and jobs
- Post ads
